Bright Minds Biosciences Inc. (CSE:DRUG)

Bright Minds Biosciences Balance Sheet

Financials in millions CAD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Cash & Equivalents	309.69	82.91	5.72	6.75	11.63	19.76
Cash & Short-Term Investments	309.69	82.91	5.72	6.75	11.63	19.76
Cash Growth	456.20%	1349.43%	-15.23%	-41.97%	-41.15%	2370.22%
Other Receivables	1.14	0.41	0.05	0.04	0.16	0.11
Receivables	1.14	0.41	0.05	0.04	0.16	0.11
Prepaid Expenses	1.46	0.99	0.22	0.03	0.16	0.17
Total Current Assets	312.29	84.31	5.99	6.81	11.95	20.04
Property, Plant & Equipment	0.07	0.11	0.12	0.07	0.14	-
Other Intangible Assets	-	-	-	-	-	0
Total Assets	312.37	84.42	6.1	6.88	12.09	20.04
Accounts Payable	3.63	1.71	0.41	0.18	1.25	0.6
Accrued Expenses	0.12	0.54	0.04	0.03	0.16	0.04
Current Portion of Leases	0.08	0.08	0.08	0.07	0.07	-
Total Current Liabilities	3.83	2.34	0.53	0.28	1.47	0.64
Long-Term Leases	-	0.04	0.04	-	0.07	-
Total Liabilities	3.83	2.38	0.57	0.28	1.54	0.64
Common Stock	365.78	123.25	35.42	33.91	32.24	27.08
Retained Earnings	-64.6	-46.58	-34.35	-31.55	-24.17	-9.21
Comprehensive Income & Other	7.36	5.37	4.46	4.23	2.48	1.53
Shareholders' Equity	308.53	82.04	5.54	6.6	10.54	19.4
Total Liabilities & Equity	312.37	84.42	6.1	6.88	12.09	20.04
Total Debt	0.08	0.13	0.12	0.07	0.14	-
Net Cash (Debt)	309.61	82.78	5.6	6.67	11.49	19.76
Net Cash Growth	457.72%	1377.97%	-16.08%	-41.90%	-41.86%	2370.22%
Net Cash Per Share	39.13	12.04	1.30	1.79	4.65	11.01
Filing Date Shares Outstanding	9.81	7.79	6.99	4.46	3.74	2.37
Total Common Shares Outstanding	9.81	7.64	4.52	3.77	3.52	2.37
Working Capital	308.46	81.97	5.46	6.53	10.48	19.4
Book Value Per Share	31.44	10.74	1.22	1.75	3.00	8.20
Tangible Book Value	308.53	82.04	5.54	6.6	10.54	19.4
Tangible Book Value Per Share	31.44	10.74	1.22	1.75	3.00	8.20

Source: S&P Global Market Intelligence. Standard template. Financial Sources.